Wednesday, 29 April 2020

Dietary Supplements Market Regional Insights, Trends, Revenue & Forecast To 2026


The dietary supplements market is anticipated to reach USD 349.4 billion by 2026 according to a new study published by Polaris Market Research. In 2019, the vitamins segment dominated the global market, in terms of revenue. Asia-Pacific is expected to be the leading contributor to the global market revenue during the forecast period.

A significant increase in the obese population, changing lifestyles, and initiatives and funding by governments to promote healthy lifestyles primarily drive the growth of this market.  Other driving factors include increasing diseases associated with obesity, increasing disposable income, and increasing awareness regarding health and nutrition. The increase in obesity related diseases such as diabetes and hypertension along with sedentary lifestyles of consumers further propel the adoption of dietary supplements. The number of memberships for health clubs and gyms has increased significantly over the years, further promoting the growth of dietary supplements. Increasing demand in developing nations is expected provide numerous growth opportunities to the market players during the forecast period.

Get Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/dietary-supplements-market/request-for-sample

There has been a significant increase in obesity across the world. In 2015, 2.2 billion people, including children and adults, were reported to be obese. A significant increase in child obesity has also been registered over the past years. The highest level of obese child and young population has been reported in the U.S. while the highest adult obesity has been reported in Egypt. Obese people have greater chances of acquiring obesity related diseases such as Diabetes and cardiovascular diseases. These increasing concerns about healthy living coupled with increasing awareness regarding proper nutrition have encouraged consumers to adopt dietary supplements, thereby promoting the growth of the market. 
  
Improvement in lifestyle due to rise in income level, especially in the developing countries of Asia-Pacific fuels the demand for dietary supplements market. Factors such as increase in per capita income and changes in consumer behavior towards nutrition and healthy eating habits are expected to accelerate the adoption of dietary supplements in the coming years.

Asia-Pacific generated the highest revenue in the market in 2019, and is expected to lead the global market throughout the forecast period. The high geriatric population in the region coupled with increasing disposable income drives the market growth. The sedentary lifestyle of consumers in the region has encouraged them to adopt dietary supplements to stay healthy and acquire proper nutrition. Increasing disposable incomes in developing countries of this region, rising awareness about health benefits of dietary supplements, and growing presence of fitness centres further foster the growth in this region.

Any Special Requirement | Speck to our Industry Expert @   https://www.polarismarketresearch.com/industry-analysis/dietary-supplements-market/speak-to-analyst


The different end-users in the market include adults, children, infants, pregnant women, and geriatric. In 2019, adults accounted for the highest market share. However, adoption of dietary supplements in children is expected to grow at the highest CAGR during the forecast period. The increasing demand for dietary supplements in children is owing to increasing need for proper nutrition, reduce chances of illness, and decrease incidences of child obesity.

The well-known companies profiled in the report include Abott Laboratories, GlaxoSmithKline, Herbalife International, Bayer AG, Pfizer Inc., Nutraceutics Inc., Glanbia Nutritionals, Amway, Carlyle Group, Arkopharma Laboratoires Pharmaceutiques, Bionova Lifesciences, and Danisco A/S among others. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers.

Contact Us:
Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com


on No comments:
Labels:

Digital Signage Market Demand, recent trends, Major Driving Factors and Business Growth Strategies

According to a new study published by Polaris Market Research the global digital signage market is anticipated to reach USD 34.9 billion by 2026. Digital signage helps the companies to promote their products and services using creative ideas, thus reaching out to a large number of audiences at a single time. Digital signages uses audio visuals, thus eliminating the need for printed materials. They are also used for information sharing with the help of self-service kiosks and information kiosks. Different industry verticals are adopting to this technology, owing to its cost effectiveness and due to the ease of content sharing.

The data on digital signages can be shared simultaneously to different screens installed at different locations, thus reducing the time and cost and helps in providing better control over the data displayed. Due to these advantages, the market for digital signage is projected to gain traction over the forecast period.

Displays play a major role in the overall digital signage market. Display technologies such as LCD, LED and projection are widely used. Currently the market for LCD is high, however with the growing adoption of LED display panels, the market for LED display is anticipated to gain traction during the forecast period. This is majorly due to the flexibility, brightness and clarity which these LED screens provide. There are different types of digital signages which are being used in the market which include transparent LED screens, video walls, video screens digital posters and kiosks.

Get Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/digital-signage-market/request-for-sample

The market share for video screens is high, however video walls are estimated to gain a larger market share due to its increasing usage in different industry verticals. These video walls can be used both indoors and outdoors and can be installed and implemented according to the different shapes of the buildings. Kiosks on the other hand are being used widely in educational institutes, offices and malls for self-help and are estimated to gain traction.

Digital signage components which include hardware, software and service are also gaining a good traction in the market. Hardware is one of the crucial component for digital signage, since it is used for displaying the information. This hardware is expensive and majorly include screens, connectivity hardware and sensors. Software on the other hand helps to display and upload the content on these screens and help them to connect with the central servers. The service segment includes installation and maintenance of these hardware and software. It is estimated that the market for hardware would gain a significant traction followed by software and service segment during the forecast period.

Any Special Requirement | Speck to our Industry Expert @  https://www.polarismarketresearch.com/industry-analysis/digital-signage-market/speak-to-analyst

Retail sector is one of the largest adopter of the digital signage technology followed by banking, transportation, government and hospitality industry. This adoption by the retail sector is due to the increasing need and requirement of the retail stores to promote their products, service, offerings in a more attractive way to attract more customers. Along with this sector, the transportation vertical incorporates the use of computerized advertising and screens at airplane terminals, railroad stations, metro platforms, and transport stands. Furthermore, the digital screens are additionally utilized on the streets, over and inside taxis, public transport systems, and on terminals for information sharing as well for advertisements. This increased usage and application in different verticals is boosting the global market for digital signage.

Contact Us:
Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com
on No comments:
Labels: , ,

Fog Computing Market Global Demand, Industry Growth,In-depth Analysis and Opportunities till 2026

According to a new study published by Polaris Market Research the global fog computing market is anticipated to reach USD 934 million by 2026. Fog computing helps in enhancing the efficiency as well as data computing competencies for cloud computing. The major use of fog computing is to enhance efficiency however, the use of fog computing can also be done for security and compliance reasons. Fog computing is used in several applications including, smart city, smart buildings, smart grid, vehicle networks and software- defined networks.

On the basis of components, the market is segmented into hardware and software. The software market is growing at a highest CAGR and has accounted for the largest share attributed to low cost, increasing functionality, as well as advancements in features & designs. Furthermore, the constantly decreasing costs of sensors, storage devices, and semiconductor devices is one of the factor which is fueling the market growth of hardware in fog computing. Another factor responsible for the market growth of fog computing is the developments in network technology resulting in reduction of OPEX across business organizations.


Major companies profiled in the report include Cradlepoint, Inc., PrismTech, FogHorn Systems, Cisco Systems, Inc., Crosser Technologies, Nebbiolo Technologies, Microsoft Corporation, Intel Corporation, Fujitsu, Arm Holding Plc., and ADLINK Technology Inc.


Currently, the market for fog computing is dominated by North America with countries including, US and Canada taking initiatives to promote the adoption of IoT in the region. Also, Europe is the second largest market after North America, which is also experiencing growth in the adopting of fog computing and IoT. However, APAC is expected to witness high growth during the forecast period attributed to the increasing awareness of fog computing in these regions.


Key Findings from the study suggest North America is expected to command the market over the forecast years. APAC is presumed to be the fastest growing market, with highest CAGRover the forecast period. The fog computing market is presumed to develop at a CAGR of over 62.6% from 2018 to 2026. The fog computing technology is used in applications such as building & automation, smart energy, transportation & logistics, smart manufacturing, connected health, and others. Among the application segment, smart manufacturing is expected to hold the largest share. This is due to the several number of sensors required for varied functions in manufacturing facilities, that generates enormous amount data. Fog computing helps manufacturing companies to reduce operating cost by making use of real-time data to take efficient decisions.

Contact us-
Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com



on No comments:
Labels: , ,

Monoclonal Antibodies mabs Market Historical Growth, Regional Trends, Forecast 2026

According to a new study published by Polaris Market Research the worldwide monoclonal antibodies market is anticipated to reach over USD 148.9 billion by 2026. In 2017, by indication, the cancer segment dominated the global market in terms of revenue; wherein fully-human monoclonal antibodies held a major share of the market. In terms of geography, North America accounted for the majority share in the global monoclonal antibodies market.

The monoclonal antibodies (mAbs) market is mainly driven by an active pipeline, wherein many monoclonal antibodies are at the different stages of drug development. In addition, increased in research and development, favorable government policies and rising prevalence of cancer and other chronic diseases supplement the market growth. The other factors that augment that market growth include the increasing the demand for personalized medicine and rising awareness among medical professional and patients about the latest medical therapies. Moreover, emerging targets such as central nervous system disorders, price correction and new delivery strategies for monoclonal antibodies provide opportunities for market growth in the near future.




Monoclonal antibodies constitute a major share of the pharmaceutical market with several monoclonal antibodies still in the pipeline. With over 30 monoclonal antibodies approved for use by regulatory authorities, many monoclonal antibodies are in the pipeline at the pre-clinical stage and various stages of clinical trials. Furthermore, availability of advanced technology for monoclonal antibodies production has egged on many other market players to develop their own pipelines. Also, in the last few years the patents of many monoclonal antibodies have expired thereby encouraging other pharmaceutical companies to undertake production of monoclonal antibodies.

There has been an increase in the research and development activities in the field of monoclonal antibodies. Several biomedical and technological advances in genetic engineering and next generation genome sequencing have fuelled the growth of the monoclonal antibody market. Also, multiple new targets have been identified during preclinical research, which has led to the development and production of newer monoclonal antibodies by using various cytotechnological methodologies. In addition to this, favorable government initiatives to enable cost-effective production of monoclonal antibodies would give impetus to the monoclonal antibodies market growth. Also, pre-defined guidelines by regulatory bodies would ensure the safe, effective and high quality manufacturing of monoclonal antibodies Recently, the European Commission approved the first biosimilar mAb Celltrion’s Truxima (biosimilar rituximab), thereby boding well for its potential approval in the U.S.
  


Based on indication, the global monoclonal antibodies market is segmented in to cancer, inflammation, cardiovascular diseases, transplant rejection, respiratory and infectious diseases. The cancer segment is expected to lead the market during the forecast period owing to rapidly expanding patient pool, awareness about monoclonal antibodies among physicians and patients, improving medical facilities, high spending power in developed countries and increasing disposable incomes in developing countries.

The leading companies operating in this industry include Pfizer, Inc., GlaxoSmithKline PLC, Novartis AG, Merck & Co., Inc., Eli Lily & Co., AstraZeneca, Amgen, Inc., Abbott Laboratories, Thermo Fisher Scientific, Inc., Bistro-Myers Squibb. Mylan N.V., Daiichi Sankyo Company, Ltd., Bayer AG, Hoffmann-La Roche Ltd., and Novo Nordisk A/S. The market players have adopted various strategies such as novel product development, new product release, and venture capital investments among others to establish a foothold in the market and increase their customer base.


Contact us-
Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com
on No comments:
Labels: ,

Microscope Market Report is best solution to Growing Economical Trend by 2020-2025

According to a new study published by Polaris Market Research the worldwide microscope market is anticipated to reach USD 12,851.2 million by 2025. In 2017, the electron microscope segment dominated the global market, in terms of revenue, whereas Asia-Pacific accounted for the majority share in the global microscope market.

Several technological advancements in the fields of nanotechnology, semiconductors and life sciences have augmented the growth of the microscope industry. In addition, this has encouraged government bodies to invest in research and development; which in turn has led to an increase in research and development activities in companies, small laboratories and academic institutions. Companies and academic institutions are increasing collaborations for shared use of advanced laboratory equipment has further supplemented market growth. The other factors driving the market growth include lightweight and portability of certain microscopes production of robust, more accurate and relatively cheaper instruments, and widespread adoption of microscope use by manufacturers across various domains. Emerging market in developing countries and newer innovative fields of application provide numerous opportunities for growth.


The major driver of the growth of the microscope market is the advancements in the field of nanotechnology. Various factors such as optimal energy consumption and its conservation, environmental preservation, and increasing industrial productivity and quality by optimizing operational efficacy have fuelled the growth of nanotechnology. Also, miniaturization in semiconductor and electronics industry and material science has boosted market growth. Furthermore, the extensive use of microscopes and technological advancements in the field of forensic sciences, pharmacology, cell biology, biophysics and microbiology among other life sciences has augmented market growth.
  
In view of increasing technological advancements and its benefits, there has been an increase in the research and development activities in companies, small laboratories and academic institutions. It has also encouraged the government bodies to increase funding of such research and development activities. Moreover, companies and academic institutions are collaborating in order to use advanced laboratory equipment, which in turn has also supplemented market growth.

The recent technological advancements in the manufacturing process of microscopes has led to the production of robust, more accurate and relatively cheaper instruments. In addition, certain microscopes are lightweight and portability in nature which has further contributed to the market growth. Furthermore, recent advancements in commercial applications of nanotechnology, life science and semiconductor manufacturing has led to a widespread adoption of microscope use by manufacturers across various domains.


Asia-Pacific dominates the global market and is predicted to exhibit growth at the highest CAGR during the forecast period. This rapid growth is due to the swelling economic growth in countries such as China and Japan. Various factors governing the growth in this region include presence of major market players in this region, increasing government and rapidly increasing research and development activities. Furthermore, various technological advancements in the field of material and life sciences, and nanotechnology is further boosting the market growth.

 The different types of microscopes include optical microscopes which is further categorized into inverted microscopes, stereomicroscopes, phase contrast microscopes, fluorescence microscopes, confocal scanning microscopes, near field scanning microscopes, other optical microscopes; electron microscope which is further categorized into transmission electron microscope which is further categorized into scanning electron microscope; scanning probe microscope; and others. The electron microscope segment is expected to dominate the market during the forecast period owing to technological advancements, in the fields of material and life sciences. Electron microscope segment is further sectioned into scanning electron microscope and transmission electron microscope.

The key market players profiled in the report include Nikon, Carl Zeiss AG, Leica Microsystems, Hitachi High Technologies, Bruker Corporation, NT-MDT Company, FEI Company, Jeol Ltd., Olympus Corporation, Asylum Research, Omax Corporation, Amscope, Celestron, Motic and Magnus Analytics. These market players have adopted various strategies such as such as new product release, novel technology development and collaboration among others to expand their foothold and increase their customer base.

Contact us-
Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com


on No comments:
Labels: , , ,

Industrial Internet of Things (IIoT) Market Growth Opportunities to Tap into in 2020-2026

According to a new study published by Polaris Market, the global Industrial Internet of Things (IIoT) market is anticipated to reach USD 771.72 billion by 2026. Industries worldwide are looking for new business models to construct a connected enterprise for merging their operational and information departments. This transformation is expected to enhance the overall productivity, operational efficiency, and visibility as well as decrease the complexities of diverse procedures in the industry. The capability of IIoT to decrease costs is the major factor responsible for its high adoption by the industries. Other factors include increased productivity, time-to-market, and process automation. Moreover, decreasing sensors prices has also helped in the reduction of overall costs related to data collection and analytics.

The role of IIoT is becoming more prominent in allowing easy access to machines and devices. The adoption of IIoT is further anticipated to escalate globally attributed to increasing innovative efforts by major players such as GE, Cisco and Huawei, as well as increasing initiatives sponsored by governments. For instance, the government of Germany is sponsoring a multi-year strategic initiative ‘Industrie 4.0’, focused on uniting the major participants from public and private sectors along with academia for the creation of an action plan and a broad vision to implement digital technologies in the country’s industrial sector. Furthermore, “Made in China 2025” initiative of the Chinese government is helping the promotion and integration of digital technologies in the industrial sector of China.


  
The market in the Asia Pacific region is projected to grow at the fastest CAGR owing to considerable adoption of IIoT in the countries such as Japan, Taiwan and China. Manufacturing companies across these countries are recognizing the advantages offered by the implementation of IIoT in their production line. China is the dominating country in the Asia Pacific market due to the presence of several manufacturing companies in the region and high adoption of automation technologies.

Some of the major players operating in the Industrial IoT include Corning Incorporated, ABB Ltd., Cisco Systems, Inc., General Electric Company, Siemens AG, Rockwell Automation, Inc., IBM Corporation, Microsoft Corporation, ARM Ltd., Intel Corporation, and Kuka AG among others.


Contact us-
Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com
on No comments:
Labels: ,

Hemophilia A Treatment Market Future Technological Trends and Business Opportunities By 2026

Hemophilia A patients have begun to shift from short acting to EHL factors and from on demand therapies to prophylactics. The increasing prevalent population of Hemophilia A and the rise in demand of the prophylactics treatments in developed markets will have a great impact on this market.

According to the US Centers for Disease Control and Prevention, hemophilia A occurs in 1 in 5,000 live male births. Hemophilia A is about four times as common as hemophilia B.  The number of people with hemophilia in the United States is estimated to be about 20,000 individuals. Approximately 75% of people with hemophilia around the world still receive inadequate treatment or have no access to treatment.


As of January 2018, there are over 450 reported Clinical Trials for Hemophilia A with 50+ trials currently actively ongoing. Out of all the trials, 120+ studies are funded by the pharmaceutical companies alone. The major players with drugs in Phase III are Alnylam Pharmaceuticals, Sanofi (Genzyme), BioMarin Pharmaceutical, Hoffmann-La Roche, Sinocelltech Ltd., Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd, Octapharma, LFB USA, Inc., Novo Nordisk A/S, Pfizer and others.

Polaris Market Research expects that with the expected launch of the promising treatments, the market is expected to expand in Hemophilia A segment. The United States dominates the Hemophilia A treatment market followed by Europe 5 and Japan. The prophylaxis segments are predicted to be the fastest growing segment whereas the on-demand therapy segment is expected to contribute close to ~50% to the market during the forecast period. With the increase in the R&D investments and rising drug innovations in this field, the market is expected to significantly expand in the next five years.

Have Questions? Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/hemophilia-a-treatment-market/inquire-before-buying

RNA based therapeutics and curative gene therapies are rapidly progressing through clinical development and are seen as an attractive segment of this market.

Polaris Market Research has provided the forecasts of the Global Hemophilia A Market from 2016-2022. The major segments which has been investigated in the global market from 2016-2022 are:

  • Market Analysis by Hemophilia A treatment
  • Market Analysis by Treatments/Marketed Drugs
  • Market Analysis by G7 countries


The Marketed Therapies undertaken in forecast from 2016-2022 are:
  • Afstyla Sales Forecast-2016-2022
  • Eloctate Sales Forecast-2016-2022
  • Hemlibra Sales Forecast-2016-2022
  • Kogenate FS Sales Forecast-2016-2022
  • Kovaltry Sales Forecast-2016-2022
  • Nuwiq Sales Forecast-2016-2022
  • Obizur Sales Forecast-2016-2022


The Major Indications in Hemophilia A Therapy area:
  • Prophylaxis-Market Forecast 2016-2022
  • On-demand therapy-Market Forecast 2016-2022
  • Inhibitor therapy- Market Forecast 2016-2022


The Market Forecast of Hemophilia A Treatment by G7 Countries (2016-2022)
  • United States- Market Forecast (2016-2022)
  • Germany- Market Forecast (2016-2022)
  • France-Market Forecast (2016-2022)
  • Italy- Market Forecast (2016-2022)
  • Spain- Market Forecast (2016-2022)
  • United Kingdom- Market Forecast (2016-2022)
  • Japan- Market Forecast (2016-2022)


Leading Companies investigated in the Report are
  • CSL Behring
  • Shire
  • Bayer
  • Biogen
  • Genentech
  • Bioverativ
  • Alnylam Pharmaceuticals
  • Sanofi (Genzyme)
  • BioMarin Pharmaceutical
  • Hoffmann-La Roche
  • Sinocelltech Ltd.
  • Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
  • Octapharma
  • LFB USA, Inc.
  • Novo Nordisk A/S
  • Pfizer


Contact us-
Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com

on No comments:
Labels: , ,

Eubiotics Market Outlook | Development Factors, Latest Opportunities and Forecast 2026

The global eubiotics market is expected to reach more than USD 8.60 billion by 2026 with a CAGR of 5.6% during the forecast period as per a new study released by Polaris Market Research. The report “Eubiotics Market [By Ingredient Type (Prebiotics, Probiotics, Organic Acids, Essential Oil); By Functionality (Yield, Productivity, Immunity, Nutrition & Gut Health); By Application (Poultry, Cattle, Aquaculture, Swine); By Regions]: Market size & Forecast, 2017 – 2026”. provides an extensive analysis of present market dynamics and predicted future trends.

Now-a-days there are many stringent regulations on the usage of antibiotic growth promoters. There has also been a pressure from consumer towards food safety, these two are the main drivers to drive the growth of eubiotics.



The specific organic acid such as essential oil compounds, benzoic acid, probiotics and nucleotides can be used as a single product or can be combined with two or more eubiotics to achieve quality result. Prebiotics can be defined as a specific kind of micro-organism that helps to improve the balance of pathogenic to beneficial bacteria. Prebiotics comes under non-digestible oligosaccharides that serves subtract for probiotics and helps to compete with pathogens which helps to regulate` the gut cell adhesion.

Eubiotics are used for weaning piglets at the time of transition from suckling milk to feeding solid feed. This also helps in preventing bacteria growth and helps to improve digestion of feed ingredients. It is also used in the form of benzoic acid as preservatives. The usage in the food industry has also fueled the growth of eubiotics market.

There are many projects undertaken at the Pig Research Centre of the Danish Agriculture and Food Council on eubiotics. There are numerous tests taken to find the performance of eubiotics on animals. One project was undertaken where it was found that supplementation of 0.5% of benzoic acid is similar to the effect of the usage of1% benzoic acid. Piperin, an essential oil compound helps to stimulate the production of digestive enzymes. The above characteristics have led to the increase in the demand for eubiotics.

Have Questions? Inquiry before buying this report by clicking the link below: 
 https://www.polarismarketresearch.com/industry-analysis/eubiotics-market/inquire-before-buying

Key Findings from the study suggest that the largest share of the eubiotics market in 2017 was of the Europe region. Europe was the first region to put a ban on use of antibiotics as growth promoters. Increasing concerns of animal safety and nutrition that eventually lead to components of processed meat for humans are the major concerns for the region’s ban on antibiotics. This ban created remarkable opportunities for the eubiotics which are the direct substitutes.   

The top key players in Eubiuotics market are Cargill, BASF SE,DSM N.V., Koninklijke, Kemin Industries, Novozymes, Addcon, Novus International Inc, Lallemand Inc, Chr. Hansen Holding A/S

Contact us-
Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com

on No comments:
Labels: , , ,

eClinical solutions Market Deep Company Profiling of Leading Players 2020-2026

the global eClinical solutions market is anticipated to reach over USD 12,985 million by 2026. According to a new study published by Polaris Market Research, In 2017, the CTMS segment dominated the global market, in terms of revenue. In 2017, North America accounted for the majority share in the global eClinical solutions market.
The key players profiled in the report are Oracle Corporation, Parexel International Corporation, Medidata Solution, Inc., DataTrak International, Inc., CRF Health, OmniComm Systems, BioClinica Inc., eResearch Technology, eClinical Solutions, Inc., and PHT Corporation. The prominent players operating in the industry have adopted various strategies such as mergers and acquisition, product innovation and expansion, and R&D of innovative products.

Government organizations across the globe have implemented stringent guidelines to obtain error-free authentic clinical data due to the burgeoning number of clinical data research. EClinical data software facilitates processing of real-time data entries. Moreover, the need to process massive amount of data in the least possible time increases the adoption of these solutions.

The governments of various countries across the globe have sanctioned funds to promote clinical research of novels drugs. Increase in incidence of diseases across the globe has enforced government agencies to expedite the process of drug approval. The adoption of clinical data management systems has increased in the recent years to process the queueing molecules in the development phase of clinical research.

Technological advancements in eClinical software such as use of cloud computing to secure the data and improve accessibility across remote locations are expected to boost the market growth. Cloud based solution software dominated the global market in 2017, owing to the ease of delivery and convenience of upgrading to advanced versions. This segment has been gaining traction in the recent years, and is expected to grow at the fastest rate during the forecast period.

Several pharmaceutical organizations have deployed eClinical solution software to comply with the norms of the regulatory bodies for processing clinical data without errors and without any scope for manipulation. According to the ALCOA standard, the use of electronic clinical outcome assessments (eCOA) is essential in clinical trials, as these use smartphones, tablets, and personal computers to allow patients, clinicians, and their caregivers to directly report outcomes, which ensure highly productive data for better understanding of patient experience and faster approval process.
Among end users, the CROs segment is expected to grow at the fastest rate due to the ongoing trend of outsourcing clinical research operations to these third party organizations to save time and cost. As most of the drugs that have cleared Phase III clinical trials can be marketed under FDA norms with proper recommendations and guidelines through a new drug application (NDA), a majority of the drugs across the globe are in this phase of clinical research. Hence, most of the clinical data management systems were used for conducting phase III clinical trials.
Contact us-
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com
on No comments:
Labels: , , ,

Blood Testing Market Historical Growth, Regional Trends, Forecast 2026

According to a new study published by Polaris Market Research the worldwide blood testing market is anticipated to reach USD 65,464.3 million by 2026. In 2017, the glucose testing segment dominated the global market, in terms of revenue, whereas geographically, North America accounted for the majority share in the global blood testing market.

Increasing dependency of doctors on blood-based diagnosis to ensure reliable and rapid treatment, along with rapidly growing geriatric population are the major factors which drives the blood testing device market. Moreover, surge in the demand for blood donations and organ donors, and increasing awareness about the safety of donated blood further increase the market growth. The other key factors enhancing the global market growth include multiplying prevalence of infectious diseases such as bacterial and viral diseases and other health-related disorders such as HIV, cancer, thyroid, and genetic disorders, and the exponential increase in the number of point of care (POC) testing. Use of self-testing products and home diagnostic tests, blood testing in under-developed countries, and research and development for developing new testing technologies further provide growth opportunities for the blood testing market in the forecast period.


In the era of rapid and effective medical treatments, physicians and other medical personnel are dependent on various types of laboratory testing in order to make an accurate diagnosis and carry out subsequent treatment measures. Thus, increasing reliance on physicians for blood-based diagnosis to ensure reliable and rapid treatment procedures are the factors anticipated to enhance the blood testing market in the forecast period. Generally, the elderly population who are susceptible to age-related diseases such as diabetes and cardiovascular diseases require more frequent blood testing. Furthermore, the elderly population undergoes complex surgical procedures such as dialysis, joint replacements and cancer therapies which requires blood transfusions. These factors are anticipated to bolster the demand for blood testing in the upcoming years.
  
Recent times have witnessed an increase in the prevalence of infectious diseases such as bacterial and viral diseases, and other disorders such as HIV, cancer, thyroid, and genetic disorders in all age groups and population. Blood testing plays a vital role in the identification of the causative agents of these diseases and disorders thereby boosting the growth of this market.  Also, the growing number of POC testing has led to the increased growth of the market.



Asia Pacific is anticipated to grow at the highest CAGR during the forecast period owing to the increasing economic growth in developing economies such as India, China and Japan. Various factors governing the growth in this region include large patient pool, increasing ageing population, rising standard of living, high disposable income, increasing health awareness, and improving medical facilities. Furthermore, global players are tapping into these countries, which in turn are expected to boost the market growth.

The different types of blood testing include glucose testing, lipid profile, liver function tests, prostate specific antigen, hormones, blood urea nitrogen, high-sensitivity c-reactive protein, thyroid stimulating hormone, serum nicotine/cotinine and others. The glucose testing segment is expected to dominate the market during the forecast period due to increasing population of diabetic patients and changing lifestyles. Blood glucose testing is conducted by both laboratories and point of care testing.

The major market players profiled in the report include Abbott Laboratories, Alere, Inc., Becton Dickinson and Company, Bio-Rad Laboratories, Beckman Coulter, bioMérieux SA, Biomerica Inc., Bruker Corporation, Nanosphere Inc., Nipro Diagnostics, Roche Diagnostics, Siemens AG, Thermo Fisher Scientific Inc. and Trinity Biotech PLC among others. These market players have adopted various strategies such as merger & acquisitions, novel product development, and venture capital investments among others to expand their foothold and increase their customer base.


Contact us

Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com
on No comments:
Labels: , , ,
Subscribe to: Posts (Atom)